Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Debt / NOTE 1.000% 9/1
-
Market price (% of par)
-
111.08%
-
Total 13F principal
-
$229,551,000
-
Principal change
-
-$204,000
-
Total reported market value
-
$255,520,000
-
Number of holders
-
17
-
Value change
-
-$523,187
-
Number of buys
-
5
-
Number of sells
-
7
Institutional Holders of CARDLYTICS INC - NOTE 1.000% 9/1 as of Q4 2021
As of 31 Dec 2021,
CARDLYTICS INC - NOTE 1.000% 9/1 was held by
17 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$229,551,000
in principal (par value) of the bond.
The largest 10 bondholders included
CITADEL ADVISORS LLC, Linden Advisors LP, WOLVERINE ASSET MANAGEMENT LLC, CAPSTONE INVESTMENT ADVISORS, LLC, GABELLI FUNDS LLC, GUARDIAN POINT CAPITAL, LP, LAZARD ASSET MANAGEMENT LLC, 683 Capital Management, LLC, DeepCurrents Investment Group LLC, and Nicholas Investment Partners, LP.
This page lists
17
institutional bondholders reporting positions
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.